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1. Introduction 
In a variety of tissues the bulk of hexosamine in- 
corporation into glycoprotein occurs in the micro- 
somal membranes [l] . Several studies have suggested 
that the addition of a small proportion of the total 
carbohydrate can occur while the glycoprotein poly- 
peptide is still associated with the ribosome [2-51 , 
but these results are difficult to evaluate since it has 
been shown that polyribosomes prepared from rat 
liver can become contaminated with non-ribosomal 
proteins [6, 7] . In this study the &A-secreting mouse 
plasmacytoma MPC-1 was used in experiments de- 
signed to differentiate clearly between isotopic label- 
ling due to the incorporation of hexosamine into 
nascent glycoprotein at the ribosomal site and label- 
ling caused by contamination of the preparation by 
non-ribosomal proteins. These experiments indicate 
that the ribosomal labelling observed represents the 
sum of two contributing factors: the incorporation of 
hexosamine into nascent glycoprotein and contamina- 
tion by non-ribosomal protein. A part of this study 
has been previously published as a preliminary com- 
munication [8]. 
2. Methods 
The MPC-1 plasmacytoma was maintained by 
serial transplantation in Balb/c mice. Tumour tissue 
was removed from decapitated mice, washed twice in 
0.15 M NaCl, the cells dispersed by gentle squeezing 
through a single layer of surgical gauze and washed 
in Eagle’s medium [9] The cells were resuspended 
in Eagle’s medium containing 50 mM Na pyruvate, 5% 
6 
v/v horse serum and 10 PCi of l-14C-glucosamine 
(specific activity 55 mCi/mmole), and subsequently 
incubated in stoppered flasks at 37” in an 02/CO2 
(95 :5%) atmosphere. Incubations were terminated by 
chilling to 0”. Puromycin was added to the incuba- 
tion flasks at various times during some of the ex- 
periments to a final concentration of 1 n&l; these 
incubations were continued for a further 10 min. Cells 
recovered from incubation media by centrifugation 
were homogenized in 8 ml of 0.25 M buffered sucrose 
[lo] and the homogenate centrifuged at 10,000 g 
(Rave) for 10 min. The supernatant was adjusted to 
a final deoxycholate concentration of 1% with 10% 
sodium deoxycholate in 0.03 M tris-hydrochloric 
acid buffer, pH 8.3. This suspension was centrifuged 
at 13,500g (Rave) for 10 min, the supernatant 
layered over a discontinuous gradient as described 
by Robinson [7], and the tubes centrifuged at 
102,000 g (Rave) for 210 min; the supernatants were 
retained. The polyribosomal pellets were suspended 
in 0.25 M sucrose containing tris-hydrochloric acid 
buffer pH 7.4 (50 mM), KC1 (25 mM) and MgCl2 
(5 mM) and gently homogenized. This suspension 
was centrifuged at 13,500 g (Rwe) for 10 min to 
remove undispersed material, and then at 105,000 g 
(Rave) for 60 min to sediment the polyribosomes. 
Polyribosomal pellets and their deoxycholate 
supernatants were prepared for counting by preci- 
pitation of protein with chilled 1% (w/v) trichlo- 
roacetic acid. The precipitates were washed twice 
with cold 10% (w/v) trichloroacetic acid, twice 
with chloroform: methanol: ether (1: 1:2 v/v) and 
the precipitates hydrolysed in trichloroacetic acid 
(5% w/v, 15 min, 90”); the residues were recovered 
by centrifugation. The supematants were analyzed 
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for their ribose contents according to Schneider Ill], 
and the residues dissolved in 0.5 N NaOH at 80”. 
These solutions were used for protein determination 
[ 121 and radioactivity measurements by scintillation 
counting. Analysis using methods described by Robin- 
son [ 131 showed glucosamine to be the only labelled 
substance present. 
The specific activity of UDP-N-acetyl glucosamine 
was determined in tissue incubated for 20,40 and 60 
min. Incubated cells were homogenized in 20 ml of 
absolute ethanol at - 10’) and the resulting precipi- 
tates were removed by centrifugation. The super- 
natants were reduced to dryness at room temperature 
in a rotary evaporator, the residues redissolved in water, 
and the nucleotides adsorbed onto 0.5 g of dried, acid- 
washed charcoal. The charcoal was isolated by filtra- 
tion, and exhaustively eluted with 0.03 M NH40H in 
50% ethanol. The combined eluates were evaporated, 
hydrolyzed in 3 ml of 10 N HCl (100”) 3 hr) and the 
acid removed by rotary evaporation at 60”. Hexos- 
amines were isolated on Dowex-50 (H) columns and 
eluted with 2 N HCl; a portion of this eluate was 
retained for scintillation counting and the glucosamine 
content of the remainder was determined [ 141. 
3. Results and discussion 
The RNA/protein ratios for the polyribosomes 
prepared as described fell in the range 0.90- 1.10. The 
linear incorporation of 14C-glucosamine into poly- 
ribosomes and deoxycholate-soluble protein for in- 
cubation periods up to 90 min is shown in fig. 1. Ad- 
dition of puromycin to the incubation medium at the 
times shown resulted in a sharp drop in the specific 
activity of the polyribosomes and a decline in the rate 
of increase of activity in the deoxycholate supernatant. 
If all the labelling observed represented incorporated 
hexosamine, then the addition of puromycin would 
discharge the growing polypeptides [ 151 and the 
specific activities of the polyribosomes would fall to 
similar low values irrespective of when puromycin 
was added. If on the other hand, the linear incorpo- 
ration observed was solely due to the adsorption 
50 60 70 a0 90 
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Fig. 1. Plasmacytoma tissue was incubated as described in pairs of flasks for 20,40,60 and 80 min. At the end of each incubation 
period, the control flask of each pair was withdrawn; puromycin was added to the other to a concentration of 1.0 mM. The 
puromycin-containing flasks were withdrawn after a further 10 min of incubation. Polyribosomes and deoxycholate supernatants 
were prepared from the incubated cells as described in the text. 
l = control polyribosomes o = puromycin-treated eoxycholate supernatants 
n = puromycin-treated polyribosomes A = trichloroacetic acid supematant. 
o = control deoxycholate supernatants t = time of puromycin addition. 
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of contaminating material, then the addition of puro- 
mycin would have an effect proportional only to the 
reduction in specific activity of the deoxycholate 
supernatant caused by the antibiotic. The actual de- 
creases in the polyribosomal specific activities are 
disproportionately large when compared with the 
corresponding decreases observed in the radioactivities 
of the deoxycholate-soluble protein. This finding in- 
dicates that the reduction in ribosomal radioactivity as 
a result of puromycin addition is not wholely due to a 
decrease in the specific activity of the contaminating 
supernatant protein. Furthermore, no discharge of 
labelled material occurs when contaminated poly- 
ribosomes are incubated with puromycin in vitro 
[ 161. Therefore the decreases in polyribosomal acti- 
vities indicate the presence of 14C-glucosamine-labelled 
nascent glycoprotein which is released from the poly- 
ribosomes by the puromycin. The extent of the puro- 
mycin-induced reduction in polyribosomal specific 
activity increases with progressively longer incubation 
times and reflects the slow rise to equilibrium of the 
radioactivity of the immediate precursor of incorpo- 
rated glucosamine, i.e. UDP-N-acetyl glucosamine 
(table 1). The residual radioactivity in polyribosomes 
from puromycin treated cells probably represents 
contaminating protein, since the rate of increase with 
Table 1 
incubation time (min) 20 40 60 
Specific activity of 
UDP-A’-acetylglucosamine, 
(dpm/pmole X 1 0e6) 
3.87 5.47 6.82 
Incubation time, (min) 
Drop in specific acitivity 
of polyribosomes due to 
the addition of puromycin 
(dpm/mg RNA) 
30 50 70 
47 60 78 
Plasmacytoma tissue was incubated in the presence of t4C- 
glucosamine as described in the text for 20, 40 and 60 min, 
and the specific activity of the intracellular UDP-A’-acetyl 
glucosamine determined. The drop in the polyribosomal spe- 
cific acitivities as a result of puromycin addition is calculated 
from the data of fig. 1; the figures are corrected for the cor- 
responding reduction in radioactivity in the deoxycholate 
supernatant. 
time of this residual radioactivity is proportional to 
the increase in the radioactivity of the deoxycholate 
supernatant protein (fig. 1). 
It is concluded, therefore, that the trichloroacetic 
acid insoluble (i.e. protein bound) 14C-glucosamine 
associated with polyribosomes prepared from these 
plasmacytoma cells is derived from both nascent 
glycoprotein and from contaminating supernatant 
glycoprotein. Recent observations [ 171 have also 
shown that glucosamine becomes attached to nascent 
glycoprotein in rat liver. 
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